Cargando…

Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective

Introduction Gastric varices (GV) are less commonly seen but bleed more severely than esophageal varices (EV). Transjugular intrahepatic portosystemic shunt (TIPS), alcohol injection, and N-butyl-2-cyanoacrylate (NBCA) are generally used for GV bleed management. NBCA is usually injected endoscopical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansoor-Ul-Haq, Muhammad, Latif, Abdul, Asad, Mansoor, Aziz Memon, Farooque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089629/
https://www.ncbi.nlm.nih.gov/pubmed/32226664
http://dx.doi.org/10.7759/cureus.7062
_version_ 1783509773003522048
author Mansoor-Ul-Haq, Muhammad
Latif, Abdul
Asad, Mansoor
Aziz Memon, Farooque
author_facet Mansoor-Ul-Haq, Muhammad
Latif, Abdul
Asad, Mansoor
Aziz Memon, Farooque
author_sort Mansoor-Ul-Haq, Muhammad
collection PubMed
description Introduction Gastric varices (GV) are less commonly seen but bleed more severely than esophageal varices (EV). Transjugular intrahepatic portosystemic shunt (TIPS), alcohol injection, and N-butyl-2-cyanoacrylate (NBCA) are generally used for GV bleed management. NBCA is usually injected endoscopically and is known to be quite successful in the treatment of GV bleeding. This study was conducted with the objective of determining the outcomes in patients with GV treated with NBCA. Methods We conducted a retrospective review of medical records and reports of endoscopy performed between March 2015 and June 2018 at a large tertiary care center. Patients of any age and gender having a history of chronic liver disease, those presenting with hematemesis or melena, and those who were found to have GV bleed on endoscopy and treated with NBCA were included. All the endoscopy procedures were undertaken within 24 hours of admission. Informed written consent was obtained from all the patients before the procedure. The outcomes were measured in terms of rate of mortality, hemostasis achieved, duration of stay at the hospital, and requirement of blood transfusion. Results A total of 31 patients met the inclusion criteria; (58.1%) were males and 13 (41.9%) were females. The mean age was 55.23 ±8.77 years; 12.9% were Child-Pugh class-A, 64.5% were class B, and 22.6% were class C. Out of the 31 patients, 27 (87%) patients achieved hemostasis. Moreover, 22 (71%) patients had hospital stay ranging between 5-8 days. The overall mortality rate was 9.7% (3 patients). No complication was reported from NBCA injection. Conclusion The injection of NBCA can provide a safe and effective method for the management of GV bleeding as demonstrated by the results of our study, which showed hemostasis in a majority of the cases after the initial injection with no procedure-related complications, a reduced hospital stay, and a reduced rate of mortality.
format Online
Article
Text
id pubmed-7089629
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70896292020-03-27 Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective Mansoor-Ul-Haq, Muhammad Latif, Abdul Asad, Mansoor Aziz Memon, Farooque Cureus Gastroenterology Introduction Gastric varices (GV) are less commonly seen but bleed more severely than esophageal varices (EV). Transjugular intrahepatic portosystemic shunt (TIPS), alcohol injection, and N-butyl-2-cyanoacrylate (NBCA) are generally used for GV bleed management. NBCA is usually injected endoscopically and is known to be quite successful in the treatment of GV bleeding. This study was conducted with the objective of determining the outcomes in patients with GV treated with NBCA. Methods We conducted a retrospective review of medical records and reports of endoscopy performed between March 2015 and June 2018 at a large tertiary care center. Patients of any age and gender having a history of chronic liver disease, those presenting with hematemesis or melena, and those who were found to have GV bleed on endoscopy and treated with NBCA were included. All the endoscopy procedures were undertaken within 24 hours of admission. Informed written consent was obtained from all the patients before the procedure. The outcomes were measured in terms of rate of mortality, hemostasis achieved, duration of stay at the hospital, and requirement of blood transfusion. Results A total of 31 patients met the inclusion criteria; (58.1%) were males and 13 (41.9%) were females. The mean age was 55.23 ±8.77 years; 12.9% were Child-Pugh class-A, 64.5% were class B, and 22.6% were class C. Out of the 31 patients, 27 (87%) patients achieved hemostasis. Moreover, 22 (71%) patients had hospital stay ranging between 5-8 days. The overall mortality rate was 9.7% (3 patients). No complication was reported from NBCA injection. Conclusion The injection of NBCA can provide a safe and effective method for the management of GV bleeding as demonstrated by the results of our study, which showed hemostasis in a majority of the cases after the initial injection with no procedure-related complications, a reduced hospital stay, and a reduced rate of mortality. Cureus 2020-02-20 /pmc/articles/PMC7089629/ /pubmed/32226664 http://dx.doi.org/10.7759/cureus.7062 Text en Copyright © 2020, Mansoor-Ul-Haq et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Mansoor-Ul-Haq, Muhammad
Latif, Abdul
Asad, Mansoor
Aziz Memon, Farooque
Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective
title Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective
title_full Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective
title_fullStr Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective
title_full_unstemmed Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective
title_short Treatment of Bleeding Gastric Varices by Endoscopic Cyanoacrylate Injection: A Developing-country Perspective
title_sort treatment of bleeding gastric varices by endoscopic cyanoacrylate injection: a developing-country perspective
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089629/
https://www.ncbi.nlm.nih.gov/pubmed/32226664
http://dx.doi.org/10.7759/cureus.7062
work_keys_str_mv AT mansoorulhaqmuhammad treatmentofbleedinggastricvaricesbyendoscopiccyanoacrylateinjectionadevelopingcountryperspective
AT latifabdul treatmentofbleedinggastricvaricesbyendoscopiccyanoacrylateinjectionadevelopingcountryperspective
AT asadmansoor treatmentofbleedinggastricvaricesbyendoscopiccyanoacrylateinjectionadevelopingcountryperspective
AT azizmemonfarooque treatmentofbleedinggastricvaricesbyendoscopiccyanoacrylateinjectionadevelopingcountryperspective